Skip to main content

Advertisement

Table 1 Effectiveness of perioperative intraperitoneal chemotherapy (PIC) for peritoneal carcinomatosis arising from the appendix (pseudomyxoma peritonei)

From: Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis

Chief-Investigator PIC n Median follow-up (months) Overall survival (%) Disease-free survival (%)
     1 year 3 years 5 years 10 years 1 year 3 years 5 years
Sugarbaker [5] HIPEC or EPIC (MMC) 501 48 --- --- 71.9 54.5 --- --- ---
Elias [11] HIPEC (OX or MMC) 301 88 --- --- 73 --- --- --- 56
Moran [12] HIPEC (MMC) 289 39 --- --- 87 74 --- --- 70
Choudry [15] HIPEC (MMC) 282 24 --- 67.4 52.7 --- --- 45.1 32.1
Morris [6] HIPEC (MMC) 106 23 --- --- 75 --- 71 51 38
Deraco [10] HIPEC (MMC) 104 37 --- --- 71.9 --- --- --- 38.8
Zoetmulder [8] HIPEC (MMC) 103 51.5 90 70.9 59.5 >50 --- 43.6 37.4
Sardi (PMCA) [14] HIPEC (MMC) 77 18 88 56 40 --- --- --- ---
Temple [13] HIPEC (MMC) 58 28 --- 76 62 --- --- 48 42
Current study HIPEC (OX) 58 29.1 --- --- 66.2 --- --- --- 50
  1. EPIC, early postoperative intraperitoneal chemotherapy; HIPEC, Hyperthermic intraperitoneal chemotherapy; MMC, mitomycin C; OX, oxaliplatin.